CompletedPhase 4NCT01864200

Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation

Studying Snakebite envenomation

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: BTG International Inc.
Principal Investigator: Maria Gasior, MD, MD
BTG International Inc.
Intervention: Crotalidae polyvalent immune fab (ovine)(biological)
Enrollment: 74 target
Eligibility: 12 years · All sexes
Timeline: 2013 – 2015

Study locations (18)

Georgia Regents University, Augusta, Georgia, United States
University of Kansas Hospital, Kansas City, Kansas, United States
Washington University, St Louis, Missouri, United States
University of North Carolina, Chapel Hill, North Carolina, United States
Duke University, Durham, North Carolina, United States
Vidant Medical Center, Greenville, North Carolina, United States
Lehigh Valley Hospital Center, Allentown, Pennsylvania, United States
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Palmetto Health Richland, Columbia, South Carolina, United States
St Joseph Regional Health Center, Bryan, Texas, United States
University of Texas - Southwestern, Dallas, Texas, United States
Ben Taub General Hospital, Houston, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
Scott & White Hospital, Temple, Texas, United States
+3 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01864200 on ClinicalTrials.gov

Other trials for Snakebite envenomation

Additional recruiting or active studies for the same condition.

See all trials for Snakebite envenomation →

← Back to all trials